Reaction

Cerebral Ventricle Dilatation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,144 reports · 34 co-occurring drugs

As of the last recalculation, Cerebral Ventricle Dilatation appears in 1,144 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is DARUNAVIR (PRR 61.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Darunavir4961.561.7
Lopinavir And Ritonavir3852.752.9
Misoprostol2649.749.8
Ritonavir5535.936.0
Valproate Sodium3027.127.1
Nevirapine1326.526.5
Ritonavir 100 Mg2126.026.1
Raltegravir2325.825.9
Amitriptyline Hydrochloride2021.121.1
Zidovudine1520.720.7
Atazanavir1620.520.6
Magnesium Sulfate In Water For1420.220.2
Ampicillin919.919.9
Ampicillin Sodium919.919.9
Magnesium Sulfate Heptahydrate1419.819.8
Magnesium Sulfate1419.719.8
Pyrazinamide917.617.6
Isoniazid1314.814.8
Benralizumab1614.714.8
Emtricitabine And Tenofovir Disoproxil Fumarate3413.914.0
Valproic Acid2212.912.9
Itraconazole812.512.6
Dolutegravir Sodium612.212.2
Efavirenz711.511.5
Vigabatrin911.311.3
Lamivudine1810.810.8
Tenofovir Disoproxil Fumarate Tablets510.610.6
Cefepime Hydrochloride910.210.2
Cefepime810.210.2
Alteplase89.89.8
Temozolomide108.78.7
Remdesivir68.28.2
Loratadine And Pseudoephedrine Sulfate36.96.9
Palivizumab44.84.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.